1st Quarter - Report
TODD STRATEGY GROUP for BIODESIX, INC.
Firm
Client
Income
$10,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Implementation of PO 113-93 (H.R. 4203): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M TODD | Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid |
Medical/Disease Research/Clinical Labs MED
21st Century Cures Initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M TODD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.